发明名称 HUMANIZED ANTI-HUMAN a9-INTEGRIN ANTIBODY
摘要 <p>Disclosed is a humanized anti-human a9-integrin antibody having improved activities and/or physical properties compared with a donor mouse anti-human a9-integrin antibody. Specifically disclosed is a humanized anti-human a9-integrin antibody which has a heavy-chain variable region comprising the amino acid sequence depicted in SEQ ID NO:1 or an amino acid sequence having the substitution, deletion, insertion and/or addition of one or several amino acid residues in the amino acid sequence depicted in SEQ ID NO:1 and a light-chain variable region comprising the amino acid sequence depicted in SEQ ID NO:61 or an amino acid sequence having the substitution, deletion, insertion and/or addition of one or several amino acid residues in the amino acid sequence depicted in SEQ ID NO:61. Also disclosed is a means for preventing or treating a disease of which human a9-integrin is involved in the development of the disease condition, which utilizes the antibody.</p>
申请公布号 WO2009088065(A1) 申请公布日期 2009.07.16
申请号 WO2009JP50188 申请日期 2009.01.09
申请人 JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE;ASTELLAS PHARMA INC.;UEHARA, KENJI;HIGUCHI, HIROFUMI;NAKASHIMA, TOSHIHIRO;ISHIKAWA, DAISUKE;YAMAMOTO, NOBUCHIKA;FUJITA, HIROTADA;SAKAI, FUMIHIKO 发明人 UEHARA, KENJI;HIGUCHI, HIROFUMI;NAKASHIMA, TOSHIHIRO;ISHIKAWA, DAISUKE;YAMAMOTO, NOBUCHIKA;FUJITA, HIROTADA;SAKAI, FUMIHIKO
分类号 C12N15/00;A61K39/395;A61P29/00;C07K16/28;C07K16/46;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12P21/08 主分类号 C12N15/00
代理机构 代理人
主权项
地址